China calls for deeper cooperation on internet of things

Comment

China calls for deeper cooperation on internet of things

China is calling for deeper cooperation on the internet of things among countries around the world, and to jointly launch a global demonstration platform for the IoT, said He Xuming, executive chairman of the World Internet of Things Convention.

Comment

China’s Digital Economy: The Shape of Things to Come

Comment

China’s Digital Economy: The Shape of Things to Come

Recently, the city of Wuhan announced that they will be opening a police station run solely by artificial intelligence (AI) – no employees need to apply. Although the station would be limited to vehicle and driver related administrative work, the government anticipates increasing AI use in many other areas of governance.

Comment

Strong UK-China collaborations in healthcare

Comment

Strong UK-China collaborations in healthcare

It has been a momentous month for healthcare agreements between the UK and China, with the announcement of numerous collaborations by UK companies in healthcare and life sciences with their Chinese partners

Comment

China Emerging as Internet of Things Leader

Comment

China Emerging as Internet of Things Leader

For over 30 years, Silicon Valley has been known as the world's center for digital innovation, but that perception is becoming as fresh as a flip phone. China is determined to become the world leader in the IoT, and just launched the second half of a ten-year, $US60 billion plan to cultivate domestic innovation in this space. Global IoT players with an eye toward success are thinking less about competition and more about cooperation.

Comment

Why The Internet Of Medical Things (IoMT) Will Start To Transform Healthcare In 2018

Comment

Why The Internet Of Medical Things (IoMT) Will Start To Transform Healthcare In 2018

Even though the healthcare industry has been slower to adopt Internet of Things technologies than other industries, the Internet of Medical Things (IoMT) is poised to transform how we keep people safe and healthy especially as the demand for solutions to lower healthcare costs increase in the coming years. The IoMT can help monitor, inform and notify not only care-givers, but provide healthcare providers with actual data to identify issues before they become critical or to allow for earlier invention

Comment

NHS computer problems could be to blame for ‘hundreds of deaths’, academics claim

Comment

NHS computer problems could be to blame for ‘hundreds of deaths’, academics claim

Problems with computers could be blamed for up to 900 patient deaths in the NHS a year, experts have said.

Computers are embedded across the NHS but many are "bad" and "low quality", according to two academics

Comment

Equiteq advises leading life sciences strategy consultancy Insight Strategy Advisors on its sale to Precision Value & Health

Comment

Equiteq advises leading life sciences strategy consultancy Insight Strategy Advisors on its sale to Precision Value & Health

Equiteq, the knowledge economy M&A specialist, is pleased to announce that it has advised Insight Strategy Advisors (ISA), a premier life sciences strategy consultancy, on its sale to Precision Value & Health, a part of Precision Medicine Group. ISA will become part of Precision Xtract, the global market access consultancy within Precision Value & Health.

Comment

2.5 Quintillion Reasons to use Real World Evidence

Comment

2.5 Quintillion Reasons to use Real World Evidence

NEHI puts a price on patients not adhering to treatment. It’s $290 Billion worth of a new problem for the pharmaceuticals industry – getting beyond the pill to influence the behaviours or patients and thereby influence the outcomes on which their reimbursements, and ultimately profitability, depends. Investment in patient access and adherence technology and programs is set to increase exponentially over the next five years, but if this investment is going to pay off, the data strategy to understand what patients are doing (or not doing) and why needs to be clear.

Comment

Contagious EU Pricing Models coming to a pill near you.

Comment

Contagious EU Pricing Models coming to a pill near you.

Finally it’s a reality that EU Pricing is contagious – and the US market is already showing some early symptoms including cold sweats, bouts of litigiousness, and the kind of migraine that can only be brought on by Risk Sharing Agreements.

Comment

Real-world Evidence needs to fly business class

Comment

Real-world Evidence needs to fly business class

Real-world Evidence is should be the pilot of new drug development, and it's already a business class priority. So why is so much RWE thinking still flying economy?

Comment

The Real-World Evidence Elephant

Comment

The Real-World Evidence Elephant

The Cancer Drugs Fund achieved many of its aims. It transformed access to breakthrough oncology drugs in the UK, and brought the NHS closer to the levels of access seen elsewhere in Europe. If someone had pointed to the elephant in the room, it might still be here in it's former shape. 

Comment

The Value Chromosome: or data convergence and value clarity

Comment

The Value Chromosome: or data convergence and value clarity

The value assessment frameworks introduced into the US in 2015 take a very static view of value, or more precisely value demonstration. By not considering Real-world evidence alongside trials data these new frameworks risk pushing the industry into a stalemate – increasingly complex commercial models, which are not then supported and enabled by a value assessment process which recognizes sub-populations of patients. Put simply, next-generation sequencing in genomics has pushed the envelope while definitions of value are still preoccupied with franking the mail.

Comment

25% Adapative Thinking

Comment

25% Adapative Thinking

The proper use of medicines could save the US healthcare system $213 billion annually, according to Joseph Jimenez, CEO of Novartis, in an article for the World Economic Forum. He goes on to say that, based on research, US healthcare costs could be reduced by 25% if health systems and policymakers could stop treatments that aren't working.

Comment

Young Chinese consumers want less and share more..

Comment

Young Chinese consumers want less and share more..

The modern Chinese consumer is healthier, less materialistic and more partial to home-grown brands than ever before, according to research from market analysts in Britain.

Comment

The Symptoms are the Cure.

1 Comment

The Symptoms are the Cure.

220,000 commuters, tourists, and the just plain lost travel on the London tube's Northern Line every day between 5pm and 7pm. Unless it's a Thursday when it's 219,999 as I work from home. Thanks to a wifi connection I can reduce the burden on the creaking underground system by a (very) marginal amount. And my own stress levels by a very unmarginal amount.

1 Comment

London’s life sciences companies raise record investment in 2017

Comment

London’s life sciences companies raise record investment in 2017

-London leads Europe for life sciences investment in 2017
- Companies raised £909m investment in 2017 and £2.8bn over the past five years
- 63% of the UK’s life sciences investment landed in ‘The Golden Triangle’ of London, Oxford and Cambridge

Comment

China’s middle class gets a taste for healthy eating

Comment

China’s middle class gets a taste for healthy eating

Vegetarianism and organic food are on the rise in China’s wealthier cities.

China’s heavily-laden banquet tables are under threat from changing tastes as the country’s growing middle class indulges in lighter, healthier foods.

Comment

The People Side of Consulting

Comment

The People Side of Consulting

Consulting attracts intellectual individuals, and those individuals collectively form the core product of a management consultancy. Packaging the knowledge and skills of its people, and delivering these skills through services and solutions, creates differentiation for a consulting firm.

Comment

Why China needs your scientific expertise.

Comment

Why China needs your scientific expertise.

When Raymond C. Stevens moved to Shanghai in 2011 for a nine-month sabbatical, he was curious. After spending his career in the United States, establishing a laboratory at the University of Southern California in Los Angeles and three biotechnology start-ups, the chemist sensed that China might be the next research frontier.

Comment

Long-term STP funding swallowed up ‘just keeping the show on the road’

Comment

Long-term STP funding swallowed up ‘just keeping the show on the road’

Funding that was put aside to stabilise NHS finances and support sustainability and transformation partnerships (STPs) has instead been spent on helping the service cope with immediate pressures and day-to-day costs, the government’s financial regulator has today reported.

Comment